Cleveland Clinic spinoff Clear Catheter Systems, which recently closed a $1.2 million angel investment round, has received FDA approval to sell its PleuraFlow Active Tube-Clearance System in the United States. PleuraFlow keeps catheters clear while draining blood and other fluids from the chest after heart or lung surgery.
Cleveland Clinic spinoff Clear Catheter Systems Inc. has raised $1.2 million in equity to help support the launch of its lead product, PleuraFlow.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Clear Catheter Systems has received regulatory clearance to sell its active catheter-clearance system PleuraFlow in Europe and has launched the product in markets there. So far, the spin-off from the Cleveland Clinic has the CE marking from the European Union and market approval from Health Canada, but the company is still awaiting a nod from […]
Clear Catheter Systems Inc. has won the 2009 EACTS TechnoCollege Innovation Award for its investigational catheter tube-clearing system, PleuraFlow.